37 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... Pneumocystis pneumonia (PCP ... #Prophylaxis #Opportunistic ... HIVAIDS #IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... Pneumocystis pneumonia (PCP ... #Prophylaxis #Opportunistic ... HIVAIDS #IDSA #management ... #pharmacology
Penicillins - Table of Coverage by Generation

Natural PCN  (1st generation): Benzathine PCN, PCN G 

Aminopenicillins
Generation Natural PCN ... generation): Benzathine PCN ... Coverage #Generation #Pharmacology ... Antibiotics #Table #PCN ... #Management
Cross-Reactivity of Penicillins and Cephalosporins

Cross reactivity of penicillin-allergic patients to cephalosporins has more to do with
Cephalosporins #Allergy #Management ... Reaction #Incidence #PCN ... #Pharmacology
Trick of the Trade: Naloxone Dilution for IV Use - Given that many ED overdose patients
Draw up 9 mL of ... Draw up the 1 mL ... #Management #EM ... #IM #PCC #Naloxone
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
Management of Jehovah's Witness patient in ICU 

Clarify which products may be used 
 - Discuss
Management of Jehovah's ... pts will accept PCC ... labs should be drawn ... #CriticalCare #Management
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology